Home › Tricuspid Valve Insufficiency › Washington › Seattle
Tricuspid Valve Insufficiency clinical trials in Seattle, WA
4 studies for Tricuspid Valve Insufficiency are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
EFS of the DUO System for Tricuspid Regurgitation
Recruiting
- University of Washington, Seattle
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Recruiting
- Virginia Mason Medical Center, Seattle
Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)
Recruiting
- University of Washington Medical Center, Seattle
Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients
Recruiting
- University of Washington Medical Center, Seattle
Tricuspid Valve Insufficiency trials in other cities
- New York City, NY9 studies
- Atlanta, GA7 studies
- The Bronx, NY6 studies
- Cincinnati, OH6 studies
- Nashville, TN5 studies
- Chicago, IL5 studies
- Cleveland, OH4 studies
- Rochester, MN4 studies
- Portland, OR4 studies
- Philadelphia, PA4 studies
- Minneapolis, MN4 studies
- Thousand Oaks, CA4 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer53 studies
- Cancer (all types)50 studies
- Prostate Cancer44 studies
- Breast Cancer40 studies
- Acute Myeloid Leukemia40 studies
- Metastatic Cancer39 studies
- Colorectal Cancer34 studies
- Lung Cancer33 studies
- Ovarian Cancer31 studies
- Multiple Myeloma22 studies
- Pancreatic Cancer22 studies
- Myelodysplastic Syndromes21 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.